PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $159,008 | +258.3% | 9,170 | +274.4% | 0.01% | +400.0% |
| Q2 2023 | $44,376 | +260935.3% | 2,449 | +271.6% | 0.00% | 0.0% |
| Q1 2023 | $17 | -46.9% | 659 | -59.7% | 0.00% | 0.0% |
| Q4 2022 | $32 | -100.0% | 1,635 | -69.8% | 0.00% | -50.0% |
| Q3 2022 | $113,000 | +352.0% | 5,412 | +73.3% | 0.00% | +100.0% |
| Q2 2022 | $25,000 | +56.2% | 3,123 | +37.6% | 0.00% | – |
| Q1 2022 | $16,000 | -27.3% | 2,270 | +39.3% | 0.00% | – |
| Q4 2021 | $22,000 | +100.0% | 1,630 | +130.6% | 0.00% | – |
| Q3 2021 | $11,000 | -76.1% | 707 | -55.6% | 0.00% | -100.0% |
| Q2 2021 | $46,000 | -24.6% | 1,591 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $61,000 | +110.3% | 1,557 | +24.4% | 0.00% | 0.0% |
| Q4 2020 | $29,000 | -71.0% | 1,252 | -71.7% | 0.00% | 0.0% |
| Q3 2020 | $100,000 | – | 4,425 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |